Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

New Line of DNA Amplification Reagents Promises Consistent Results Across All PCR Instruments

By BiotechDaily International staff writers
Posted on 02 Sep 2013
Image: iTaq Universal SYBR Green Supermix (Photo courtesy of Bio-Rad).
Image: iTaq Universal SYBR Green Supermix (Photo courtesy of Bio-Rad).
New reagent mixes specially formulated for PCR applications are now available for biotech and genomics researchers.

Bio-Rad Laboratories, Inc. (Hercules, CA, USA) recently launched two iTaq universal one-step kits aimed to deliver superior data precision and highly efficient reverse transcription quantitative PCR (RT-qPCR) performance under most reaction conditions on any qPCR instrument.

The new iTaq universal one-step kit line includes the iTaq universal SYBR Green one-step kit and the iTaq universal probes one-step kit. Both kits come as a double concentrated, ready-to-use reaction mixes with iScript reverse transcriptase optimized for RT-qPCR.

The iTaq universal SYBR Green one-step kit includes SYBR Green I dye and Bio-Rad’s patented RT inhibitor reducer. The iTaq universal probes one-step kit allows researchers to combine multiple targets in one well (multiplexing), improving data precision and reducing costs.

The new kits enable investigators to obtain reliable and reproducible gene expression-analysis results while amplifying genomic DNA and difficult amplicons with superior efficiency. Results are consistent across real-time instrument platforms under fast or standard conditions.

The Bio-Rad Kits are intended for gene expression analysis, genotyping, mutation detection, and pathogen detection.

Related Links:
Bio-Rad Laboratories, Inc.




Channels

Genomics/Proteomics

view channel
Image: Cancer cells, left, were pretreated with a drug that blocks the ERK signal, and right, without the pretreatment. Top cells are untreated, while the bottom ones are stimulated (Photo courtesy of the Weizmann Institute of Science).

Prevention of ERK Nuclear Translocation Blocks Cancer Proliferation in Animal Models

A team of cell biologists has shown that the cancer promoting effects of ERK dysregulation can be blocked by low molecular weight drugs that prevent translocation of this kinase from the cells' cytoplasm... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

21 Apr 2015 - 23 Apr 2015
21 Apr 2015 - 23 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.